Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-27

FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)

View source ↗

Summary

FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. It covers indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

ORIG AP for VALSARTAN (VALSARTAN)